Metabolic syndrome among people with mental illness in sub Saharan Africa: Female gender as a factor. A Systematic review and meta-analysis.
Low income setting
Mental disorder
Metabolic syndrome
Syndrome x
Journal
Annals of medicine and surgery (2012)
ISSN: 2049-0801
Titre abrégé: Ann Med Surg (Lond)
Pays: England
ID NLM: 101616869
Informations de publication
Date de publication:
May 2021
May 2021
Historique:
received:
28
03
2021
revised:
19
04
2021
accepted:
25
04
2021
entrez:
19
5
2021
pubmed:
20
5
2021
medline:
20
5
2021
Statut:
epublish
Résumé
The prevalence of metabolic syndrome among psychiatric patients in developing nations is mounting alarmingly and it is a reason for decreased life expectancy and quality of life of people with mental illness. Although great discrepant epidemiological studies have been carried out in Sub Saharan African countries, there has no systematic review and meta-analysis conducted. Therefore, summarized evidence has a paramount importance for policy makers and health planning. This study aims to estimate the prevalence of metabolic syndrome and to examine the effect of gender on metabolic syndrome among people with mental illness in sub Saharan Africa. Systematic literature search was performed using PubMed, CINAHL, Web of science, Global health electronic databases. In addition, gray literatures were retrieved from Google and Google scholar. Two authors independently extracted all the necessary data using a format prepared in Microsoft Excel. Data analysis was done using STATA Version 14 (software). The heterogeneity of the studies was assessed using I 1306 studies were reviewed and nine studies fulfilling the inclusion criteria were selected for the meta-analysis. The meta-analysis of nine studies that included 1896 participants found a prevalence rate of metabolic syndrome which was performed based on assessment criteria; JIS criteria prevalence 21.11% (95% CI: 17.93-24.29), IDF criteria 23.77% (95% CI: 15.41-32.12) and NCEP ATP-III criteria 21.63% (95% CI: 16.30-26.96). Female gender (AOR = 3.00; 95% CI: 1.98-4.55) was found to have a significant association with metabolic syndrome. The prevalence of metabolic syndrome among people with mental illness in sub Saharan Africa is high in various assessment criteria. The likelihood is significantly increased in females than males. Metabolic syndrome increases by three folds among females with mental illness as compared to their counterparts.
Sections du résumé
BACKGROUND
BACKGROUND
The prevalence of metabolic syndrome among psychiatric patients in developing nations is mounting alarmingly and it is a reason for decreased life expectancy and quality of life of people with mental illness. Although great discrepant epidemiological studies have been carried out in Sub Saharan African countries, there has no systematic review and meta-analysis conducted. Therefore, summarized evidence has a paramount importance for policy makers and health planning. This study aims to estimate the prevalence of metabolic syndrome and to examine the effect of gender on metabolic syndrome among people with mental illness in sub Saharan Africa.
METHOD
METHODS
Systematic literature search was performed using PubMed, CINAHL, Web of science, Global health electronic databases. In addition, gray literatures were retrieved from Google and Google scholar. Two authors independently extracted all the necessary data using a format prepared in Microsoft Excel. Data analysis was done using STATA Version 14 (software). The heterogeneity of the studies was assessed using I
RESULT
RESULTS
1306 studies were reviewed and nine studies fulfilling the inclusion criteria were selected for the meta-analysis. The meta-analysis of nine studies that included 1896 participants found a prevalence rate of metabolic syndrome which was performed based on assessment criteria; JIS criteria prevalence 21.11% (95% CI: 17.93-24.29), IDF criteria 23.77% (95% CI: 15.41-32.12) and NCEP ATP-III criteria 21.63% (95% CI: 16.30-26.96). Female gender (AOR = 3.00; 95% CI: 1.98-4.55) was found to have a significant association with metabolic syndrome.
CONCLUSION
CONCLUSIONS
The prevalence of metabolic syndrome among people with mental illness in sub Saharan Africa is high in various assessment criteria. The likelihood is significantly increased in females than males. Metabolic syndrome increases by three folds among females with mental illness as compared to their counterparts.
Identifiants
pubmed: 34007445
doi: 10.1016/j.amsu.2021.102351
pii: S2049-0801(21)00301-0
pmc: PMC8111264
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
102351Informations de copyright
© 2021 The Authors.
Déclaration de conflit d'intérêts
Authors declare that they have no conflict of interest
Références
Prostate Cancer Prostatic Dis. 1998 Mar;1(3):157-162
pubmed: 12496910
BMC Public Health. 2016 Apr 01;16:296
pubmed: 27039079
Electron Physician. 2017 Oct 25;9(10):5402-5418
pubmed: 29238477
BMC Med Res Methodol. 2008 Nov 27;8:79
pubmed: 19036172
Diabetes Metab Syndr Obes. 2020 Feb 27;13:569-579
pubmed: 32161483
Curr Opin Endocrinol Diabetes Obes. 2010 Oct;17(5):460-6
pubmed: 20717020
Ann Agric Environ Med. 2014;21(4):815-21
pubmed: 25528926
Lancet Psychiatry. 2016 Feb;3(2):171-8
pubmed: 26851330
Curr Hypertens Rep. 2018 Feb 26;20(2):12
pubmed: 29480368
S Afr J Psychiatr. 2017 Apr 10;23:1089
pubmed: 30263202
Biomed Res Int. 2019 Nov 11;2019:1096201
pubmed: 31815121
Dialogues Clin Neurosci. 2018 Mar;20(1):63-73
pubmed: 29946213
Nutrients. 2018 Mar 22;10(4):
pubmed: 29565803
BMJ. 2021 Mar 29;372:n71
pubmed: 33782057
PLoS One. 2016 Feb 16;11(2):e0149209
pubmed: 26882230
Diabetes Metab Syndr. 2018 Sep;12(5):753-760
pubmed: 29729979
Ann Nutr Metab. 2004;48(1):43-50
pubmed: 14646340
J Cardiovasc Dis Res. 2012 Jul;3(3):204-11
pubmed: 22923938
BMC Psychiatry. 2014 Aug 12;14:228
pubmed: 25113131
Afr J Psychiatry (Johannesbg). 2013 Nov 19;16(6):
pubmed: 24173635
BMJ. 2017 Sep 21;358:j4008
pubmed: 28935701
PLoS One. 2013 Oct 23;8(10):e78270
pubmed: 24194915
Res Synth Methods. 2010 Apr;1(2):97-111
pubmed: 26061376
Nat Clin Pract Endocrinol Metab. 2007 Oct;3(10):696-704
pubmed: 17893688
Bioinformation. 2012;8(13):613-6
pubmed: 22829741
World Psychiatry. 2015 Oct;14(3):339-47
pubmed: 26407790
Braz J Psychiatry. 2007 Dec;29(4):346-9
pubmed: 17992359
J Coll Physicians Surg Pak. 2007 Jan;17(1):32-5
pubmed: 17204217